Miami Universitywere News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nanoscope® team conferred Phase II Retinal Organoid Challenge (ROC) award by National Institute of Health
News provided by
Share this article
Share this article
BEDFORD, Texas, Feb. 2, 2021 /PRNewswire/  To meet the advance challenge for generating a physiologically relevant three-dimensional (3D) retinal organoid, Nanoscope researchers
® in collaboration with University of Colorado, and Miami University
 were recently awarded the top prize from the 3D-ROC challenge by the National Institute of Health (NIH).  https://www.nei.nih.gov/about/goals-and-accomplishments/nei-research-initiatives/3-d-retina-organoid-challenge-3-d-roc/2017-ideation-challenge/2017-ideation-winner-and-honorable-mention 
The organoids provide a unique opportunity for evaluating novel gene therapies including Multi-Characteristic Opsin (MCO) gene therapy for vision restoration. This is an active therapeutic development area for Nanoscope Therapeutics to evaluate effectiven ....

United States , Miami Universitywere , Psulagna Bhattacharya , Samarendra Mohanty , National Institute Of Health , University Of Colorado , Corporate Communications , National Institute , Multi Characteristic Opsin , Nanoscope Therapeutics , Chief Scientific , Optical Coherence Tomography , Retinitis Pigmentosa , ஒன்றுபட்டது மாநிலங்களில் , சுழஞ்நா பட்டாச்சார்யா , சமரேந்திற மொஹாண்தி , தேசிய நிறுவனம் ஆஃப் ஆரோக்கியம் , பல்கலைக்கழகம் ஆஃப் கொலராடோ , பெருநிறுவன தகவல்தொடர்புகள் , தேசிய நிறுவனம் , தலைமை அறிவியல் , ஒளியியல் இணக்கத்தைப் டோமோகிராபி ,